Attributable cost of methicillin resistance: an issue that is difficult to evaluate.

Crit Care. 2006;10(4):157.

Comment on: Crit Care. 2006;10(3):R97

Timsit JF, Groupe d'Epidémiologie des Cancers et des Affections Graves INSERM U 578, Service de Réanimation Médicale, University Hospital Albert Michallon, 38043 Grenoble Cedex, France. Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

Estimating the consequences and the cost of methicillin resistance is a difficult challenge. Patients who develop methicillin-resistant ventilator-associated pneumonia (VAP) are very different from those who develop methicillin-sensitive VAP, and biased estimates are frequent. We reviewed some important confounding factors of which the reader should be aware.